2KZT
 
 | | Structure of the Tandem MA-3 Region of Pdcd4 | | Descriptor: | Programmed cell death protein 4 | | Authors: | Waters, L.C, Strong, S.L, Oka, O, Muskett, F.W, Veverka, V, Banerjee, S, Schmedt, T, Henry, A.J, Klempnauer, K.H, Carr, M.D. | | Deposit date: | 2010-06-24 | | Release date: | 2011-03-16 | | Last modified: | 2011-11-23 | | Method: | SOLUTION NMR | | Cite: | Structure of the tandem MA-3 region of Pdcd4 protein and characterization of its interactions with eIF4A and eIF4G: molecular mechanisms of a tumor suppressor
J.Biol.Chem., 286, 2011
|
|
2MBD
 | | Lasiocepsin | | Descriptor: | lasiocepsin | | Authors: | Monincova, L, Budesinsky, M, Cujova, S, Cerovsky, V, Veverka, V. | | Deposit date: | 2013-07-30 | | Release date: | 2014-01-15 | | Last modified: | 2014-01-29 | | Method: | SOLUTION NMR | | Cite: | Structural basis for antimicrobial activity of lasiocepsin.
Chembiochem, 15, 2014
|
|
2M2N
 | |
2M2O
 | |
2M2P
 | |
2M2M
 | |
2MSR
 | | Solution structure of LEDGF/p75 IBD in complex with MLL1 peptide (140-160) | | Descriptor: | Histone-lysine N-methyltransferase 2A, PC4 and SFRS1-interacting protein | | Authors: | Cermakova, K, Tesina, P, Demeulemeester, J, El Ashkar, S, Mereau, H, Schwaller, J, Rezacova, P, Veverka, V, De Rijck, J. | | Deposit date: | 2014-08-05 | | Release date: | 2014-08-20 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Validation and Structural Characterization of the LEDGF/p75-MLL Interface as a New Target for the Treatment of MLL-Dependent Leukemia.
Cancer Res., 74, 2014
|
|
2N7E
 | |
2MPG
 | | Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue | | Descriptor: | Insulin A chain, Insulin B chain | | Authors: | Kosinova, L, Jiracek, J, Zakova, L, Veverka, V. | | Deposit date: | 2014-05-17 | | Release date: | 2014-06-11 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin.
Biochemistry, 53, 2014
|
|
2N3A
 | | Solution structure of LEDGF/p75 IBD in complex with POGZ peptide (1389-1404) | | Descriptor: | PC4 and SFRS1-interacting protein, Pogo transposable element with ZNF domain | | Authors: | Tesina, P, Cermakova, K, Horejsi, M, Prochazkova, K, Fabry, M, Sharma, S, Christ, F, Demeulemeester, J, Debyser, Z, De Rijck, J, Veverka, V, Rezacova, P. | | Deposit date: | 2015-05-26 | | Release date: | 2015-08-19 | | Method: | SOLUTION NMR | | Cite: | Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif.
Nat Commun, 6, 2015
|
|
2N7D
 | |
2MVC
 | | Solution structure of human insulin at pH 1.9 | | Descriptor: | Insulin A chain, Insulin B chain | | Authors: | Hexnerova, R, Krizkova, K, Maletinska, L, Jiracek, J, Brzozowski, A.M, Zakova, L, Veverka, V. | | Deposit date: | 2014-10-02 | | Release date: | 2014-12-10 | | Last modified: | 2016-06-01 | | Method: | SOLUTION NMR | | Cite: | Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young.
Plos One, 9, 2014
|
|
2MVD
 | | Solution structure of [GlnB22]-insulin mutant at pH 1.9 | | Descriptor: | Insulin A chain, Insulin B chain | | Authors: | Hexnerova, R, Krizkova, K, Maletinska, L, Jiracek, J, Brzozowski, A.M, Zakova, L, Veverka, V. | | Deposit date: | 2014-10-02 | | Release date: | 2014-12-10 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young.
Plos One, 9, 2014
|
|
5O2P
 | | p130Cas SH3 domain PTP-PEST peptide chimera | | Descriptor: | Breast cancer anti-estrogen resistance 1,Tyrosine-protein phosphatase non-receptor type 12 | | Authors: | Hexnerova, R, Veverka, V. | | Deposit date: | 2017-05-22 | | Release date: | 2017-09-20 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners.
Sci Rep, 7, 2017
|
|
5O2Q
 | | p130Cas SH3 domain Vinculin peptide chimera | | Descriptor: | Breast cancer anti-estrogen resistance 1,Vinculin | | Authors: | Hexnerova, R, Veverka, V. | | Deposit date: | 2017-05-22 | | Release date: | 2017-09-20 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners.
Sci Rep, 7, 2017
|
|
5O2M
 | | p130Cas SH3 domain | | Descriptor: | Breast cancer anti-estrogen resistance 1 | | Authors: | Hexnerova, R, Veverka, V. | | Deposit date: | 2017-05-22 | | Release date: | 2017-09-20 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners.
Sci Rep, 7, 2017
|
|
5ORL
 | | Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | | Descriptor: | ADENOSINE-5'-DIPHOSPHATE, Aurora kinase A, CHLORIDE ION, ... | | Authors: | McIntyre, P.J, Collins, P.M, Vrzal, L, Birchall, K, Arnold, L.H, Mpamhanga, C, Coombs, P.J, Burgess, S.G, Richards, M.W, Winter, A, Veverka, V, von Delft, F, Merritt, A, Bayliss, R. | | Deposit date: | 2017-08-16 | | Release date: | 2017-11-01 | | Last modified: | 2017-11-29 | | Method: | X-RAY DIFFRACTION (1.69 Å) | | Cite: | Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.
ACS Chem. Biol., 12, 2017
|
|
4Z2Z
 | |
7Z5A
 | |
4PVV
 | | Micobacterial Adenosine Kinase in complex with inhibitor | | Descriptor: | 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, Adenosine kinase | | Authors: | Pichova, I, Hocek, M, Dostal, J, Rezacova, P. | | Deposit date: | 2014-03-18 | | Release date: | 2014-11-26 | | Last modified: | 2024-03-20 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Structural Basis for Inhibition of Mycobacterial and Human Adenosine Kinase by 7-Substituted 7-(Het)aryl-7-deazaadenine Ribonucleosides
J.Med.Chem., 57, 2014
|
|
4RGH
 | |
5BQQ
 | | Human insulin with intra-chain chemical crosslink between modified B27 and B30 | | Descriptor: | CHLORIDE ION, Insulin, PHENOL, ... | | Authors: | Brzozowski, A.M, Turkenburg, J.P, Jiracek, J, Zakova, L. | | Deposit date: | 2015-05-29 | | Release date: | 2016-02-03 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.54 Å) | | Cite: | Rational steering of insulin binding specificity by intra-chain chemical crosslinking.
Sci Rep, 6, 2016
|
|
5BOQ
 | | Human insulin with intra-chain chemical crosslink between modified B24 and B29 | | Descriptor: | Insulin, SULFATE ION | | Authors: | Brzozowski, A.M, Turkenburg, J.P, Jiracek, J, Zakova, L. | | Deposit date: | 2015-05-27 | | Release date: | 2016-02-03 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | Rational steering of insulin binding specificity by intra-chain chemical crosslinking.
Sci Rep, 6, 2016
|
|
5BPO
 | |
3SQF
 | | Crystal structure of monomeric M-PMV retroviral protease | | Descriptor: | Protease | | Authors: | Jaskolski, M, Kazmierczyk, M, Gilski, M, Krzywda, S, Pichova, I, Zabranska, H, Khatib, F, DiMaio, F, Cooper, S, Thompson, J, Popovic, Z, Baker, D, Group, Foldit Contenders | | Deposit date: | 2011-07-05 | | Release date: | 2011-09-21 | | Last modified: | 2023-09-13 | | Method: | X-RAY DIFFRACTION (1.6324 Å) | | Cite: | Crystal structure of a monomeric retroviral protease solved by protein folding game players.
Nat.Struct.Mol.Biol., 18, 2011
|
|
